Integrated analysis of gene expression and DNA methylation datasets identified key genes and a 6-gene prognostic signature for primary lung adenocarcinoma-Reference-Cited by-同舟云学术

Integrated analysis of gene expression and DNA methylation datasets identified key genes and a 6-gene prognostic signature for primary lung adenocarcinoma

Published:2021 Issue:4 Volume:44 Page:
ISSN:1678-4685
Container-title:Genetics and Molecular Biology
language:
Short-container-title:Genet. Mol. Biol.

Author:

Meng Jing¹,Cao Lei¹,Song Huifang¹,Chen Lichun¹,Qu Zhiguo¹^ORCID

Affiliation:

1. Inner Mongolia People’s Hospital, China

Publisher

FapUNIFESP (SciELO)

Subject

Genetics,Molecular Biology

Link

http://www.scielo.br/pdf/gmb/v44n4/1415-4757-GMB-44-4-e20200465.pdf

Reference45 articles.

1. Differential expression analysis for sequence count data;Anders S;Genome Biol,2010

2. Interaction between CXCR4 and CCL20 pathways regulates tumor growth;Beider K;PloS One,2009

3. Gene-promoter hypermethylation as a biomarker in lung cancer;Belinsky SA;Nat Rev Cancer,2004

4. Controlling the false discovery rate in behavior genetics research;Benjamini Y;Behav Brain Res,2001

5. Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis;Bjaans MM;Mol Oncol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation;Cell Communication and Signaling;2023-08-25

2. The Hexosamine Biosynthesis Pathway: Regulation and Function;Genes;2023-04-18

3. Five glycosylation-related gene signatures predict the prognostic risks of lung adenocarcinoma;General physiology and biophysics;2023

4. Hypoxia-associated prognostic markers and competing endogenous RNA coexpression networks in lung adenocarcinoma;Scientific Reports;2022-12-09

5. Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma;Frontiers in Oncology;2022-11-02